Could a cheap Fat-Lowering drug shield kidneys in type 1 diabetes?
Prevention
Ongoing
This pilot study tests whether fenofibrate, a generic drug used to lower blood fats, can prevent kidney function loss in people with type 1 diabetes who are at high risk of kidney failure. Forty participants will receive either fenofibrate or a placebo for 18 months, and their ki…
Phase: PHASE2 • Sponsor: Alessandro Doria • Aim: Prevention
Last updated Jun 27, 2026 09:02 UTC